Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025 
Airbus CEO Warns Staff to Prepare for Rising Geopolitical Risks Amid Trade Tensions 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
CARLSBAD, Calif., May 10, 2017 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in two upcoming investor conferences.
- SeaSpine's management is scheduled to present on Wednesday, May 24, 2017 at 11:00 am PT at the18th Annual B. Riley Co. Investor Conference in Santa Monica, CA
- SeaSpine's management is scheduled to present on Tuesday, June 6, 2017 at 9:00 am ET at the Jefferies 2017 Global Healthcare Conference in New York, NY
Interested parties can access the live audio webcasts at http://www.seaspine.com.
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development helps SeaSpine to offer its surgeon customers a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.
Investor Relations Contact Lynn Pieper Lewis (415) 937-5402 [email protected]
